ALS gene therapy prepares to move to clinical trials in China, US
U.S. and China regulators have now cleared Sineugene Therapeutics' ALS gene therapy SNUG01 for clinical trials.| ALS News Today
U.S. and China regulators have now cleared Sineugene Therapeutics' ALS gene therapy SNUG01 for clinical trials.| ALS News Today
A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling patients in the U.S.| ALS News Today
